| Literature DB >> 19321859 |
Thomas Bee1, Emma L K Ashley, Sorrel R B Bickley, Andrew Jarratt, Pik-Shan Li, Jackie Sloane-Stanley, Berthold Göttgens, Marella F T R de Bruijn.
Abstract
The transcription factor Runx1 plays a pivotal role in hematopoietic stem cell (HSC) emergence, and studies into its transcriptional regulation should give insight into the critical steps of HSC specification. Recently, we identified the Runx1 +23 enhancer that targets reporter gene expression to the first emerging HSCs of the mouse embryo when linked to the heterologous hsp68 promoter. Endogenous Runx1 is transcribed from 2 alternative promoters, P1 and P2. Here, we examined the in vivo cis-regulatory potential of these alternative promoters and asked whether they act with and contribute to the spatiotemporal specific expression of the Runx1 +23 enhancer. Our results firmly establish that, in contrast to zebrafish runx1, mouse Runx1 promoter sequences do not confer any hematopoietic specificity in transgenic embryos. Yet, both mouse promoters act with the +23 enhancer to drive reporter gene expression to sites of HSC emergence and colonization, in a +23-specific pattern.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19321859 DOI: 10.1182/blood-2008-12-193003
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113